Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. - Concepedia

Concepedia

Publication | Closed Access

Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study.

212

Citations

0

References

2000

Year

M. Varenna, F. Zucchi, D Ghiringhelli, L. Binelli, Maurizio Bevilacqua, P. Bettica, L. Sinigaglia

Abstract

A 10 day i.v. clodronate course is better than placebo and effective in the treatment of RSDS. NTx seems to be a predictive factor for clodronate efficacy.